Effectiveness of drugs being developed and tried to treat COVID-19 patients. Clinical and bench trials to investigate less common viral inhibitors against COVID-19 such as naproxen, clarithromycin, and minocyclinethat that may exert effects on viral replication.

Respiratory Viral Infections in Exacerbation of Chronic Airway Inflammatory Diseases: Novel Mechanisms and Insights From the Upper Airway Epithelium
Integrative considerations during the COVID-19 pandemic
Traditional Chinese medicine for COVID-19 treatment
Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective

Methods evaluating potential complication of Antibody-Dependent Enhancement (ADE) in vaccine recipients.

Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
Profile of Specific Antibodies to SARS-CoV-2: The First Report
A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19
Remdesivir as a possible therapeutic option for the COVID-19
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics

Exploration of use of best animal models and their predictive value for a human vaccine.

NetNCSP: Nonoverlapping closed sequential pattern mining
Multi-city modeling of epidemics using spatial networks: Application to 2019-nCov (COVID-19) coronavirus in India
The local stability of a modified multi-strain SIR model for emerging viral strains
True epidemic growth construction through harmonic analysis
Modeling the dynamics of novel coronavirus (2019-nCov) with fractional derivative

Capabilities to discover a therapeutic (not vaccine) for the disease, and clinical effectiveness studies to discover therapeutics, to include antiviral agents.

Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
The Author’s Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR
Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic

Alternative models to aid decision makers in determining how to prioritize and distribute scarce, newly proven therapeutics as production ramps up. This could include identifying approaches for expanding production capacity to ensure equitable and timely distribution to populations in need.

She Ji: The Next Five Years
Improving epidemic surveillance and response: big data is dead, long live big data
Teaching-practice as a critical bridge for narrowing the research-practice gap
Do not violate the International Health Regulations during the COVID-19 outbreak
Will financial innovation transform pandemic response?

Efforts targeted at a universal coronavirus vaccine.

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning
Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design

Efforts to develop animal models and standardize challenge studies

Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus
COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
The COVID-19 pandemic and the use of MS Disease-Modifying Therapies
Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19

Efforts to develop prophylaxis clinical studies and prioritize in healthcare workers

The emotional impact of COVID-19: from medical staff to common people
Special attention to nurses’ protection during the COVID-19 epidemic
Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of non-emergent dermatology visits
Preparedness among Ophthalmologists: During and Beyond the COVID-19 Pandemic
Beyond the assistance: additional exposure situations to COVID-19 for healthcare workers

Approaches to evaluate risk for enhanced disease after vaccination

Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus
COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
The COVID-19 pandemic and the use of MS Disease-Modifying Therapies
An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design

Assays to evaluate vaccine immune response and process development for vaccines, alongside suitable animal models [in conjunction with therapeutics]

Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus
COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
The COVID-19 pandemic and the use of MS Disease-Modifying Therapies
Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19